Using biofluid markers to detect Alzheimer's disease early in Colombia
IMPLEMENTATION OF BIOFLUID MARKERS FOR EARLY DETECTION OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES IN COLOMBIA
This study is looking to make it easier to spot Alzheimer's and similar brain diseases by using special markers found in blood samples, and it's designed for people in Colombia to help doctors better understand and treat these conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Antioquia NIH-funded |
| Lab location | 1 site (Medellin, Colombia) |
| Project ID | NIH-11087256 on NIH RePORTER |
What this research studies
This research focuses on improving the detection of Alzheimer's disease and other neurodegenerative diseases by utilizing biofluid markers in Colombia. The project aims to integrate these markers into routine clinical practice and research, enhancing the capabilities of the Neuroscience Group at the University of Antioquia. By analyzing serum samples using advanced technology, the research will validate the effectiveness of these biomarkers in identifying patients at risk for Alzheimer's disease. This initiative is particularly significant given the unique genetic diversity of the Colombian population, which may provide valuable insights into the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Colombia who are at risk for Alzheimer's disease or exhibit early symptoms of neurodegenerative conditions.
Not a fit: Patients outside of Colombia or those without risk factors for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of Alzheimer's disease, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using biofluid markers for early detection of Alzheimer's disease, indicating that this approach has potential for success.
Where this research is happening
Medellin, Colombia
- University of Antioquia — Medellin, Colombia (Active)
Researchers
- Principal investigator: Cardona-Gómez, Gloria Patricia — University of Antioquia
- Study coordinator: Cardona-Gómez, Gloria Patricia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.